The Hidden Dangers of Liver Fat: A Small Problem with Big Consequences

Fat in the human body serves several critical functions, from storing energy to cushioning vital organs. However, not all fat is created equal. While many of us are aware of the fat that lies just beneath our skin, known as subcutaneous fat, there is another, less visible type of fat that can be far more dangerous: liver fat. Even a small increase in fat within the liver can have serious health consequences, making it crucial to understand how to manage this often-overlooked issue.

Types of Fat in the Body

In an average man who is 175 cm tall and weighs 75 kg, fat is distributed in several key areas:

1. Subcutaneous Fat: This is the fat stored just under the skin and makes up about 80-90% of total body fat, amounting to roughly 9 to 13.5 kg. It serves as insulation and protection for the body.
2. Visceral Fat: Found around internal organs like the liver and intestines, visceral fat is more dangerous than subcutaneous fat. In men it accounts for about 10-20% of total body fat, or approximately 1.1 to 3 kg.
3. Intramuscular Fat: This fat is stored within muscles and makes up a smaller share of total body fat. It serves as an energy reserve during exercise.
4. Liver Fat: Fat stored within the liver. A healthy liver already holds a little, typically 2-5%. Fatty liver (steatosis) starts when more than 5% of liver cells contain fat on biopsy, or when the liver fat fraction on MRI is above about 5.5%. It is a proportion, not a weight in grams.

The Danger of Excess Liver Fat

While it’s normal to have a small amount of fat in the liver, even a slight increase can lead to serious health issues. When more than 5% of liver cells contain fat, the diagnosis is steatotic liver disease, in most people metabolic dysfunction-associated steatotic liver disease (MASLD), still widely known as non-alcoholic fatty liver disease or NAFLD. Because a healthy liver already holds 2-5% fat, the step from normal to diseased is small.

NAFLD is not just a minor inconvenience. As it advances, it can impair the liver’s ability to perform its essential functions, including detoxifying the blood, producing bile for digestion, and managing glucose and fat metabolism. As the liver becomes increasingly fatty, it can lead to inflammation and progress to a more severe condition called non-alcoholic steatohepatitis (NASH). NASH can further develop into cirrhosis, liver failure, or liver cancer.

What makes NAFLD particularly alarming is that it often shows no symptoms until significant damage has occurred. By the time symptoms like fatigue, abdominal discomfort, or jaundice appear, the liver may already be severely compromised.

How Much Fat Needs to Be Removed?

To return a fatty liver to a healthy state, the goal is to bring liver fat back below the diagnostic threshold: fat in fewer than 5% of liver cells, or under about 5.5% on MRI. Because the threshold is a proportion, not a weight, there is no fixed number of grams to remove. What the evidence does show is how much weight loss moves it: in a meta-analysis of 43 studies, every kilogram lost lowered liver fat by about 0.77 percentage points on average.

Standard Approach for Fatty Liver Removal: Diet and Lifestyle Changes

The most common method for reducing liver fat involves diet and lifestyle modifications. These typically include:

• Caloric Restriction: Reducing overall calorie intake to promote weight loss.
• Low-Carbohydrate Diet: Minimizing the intake of sugars and refined carbohydrates, which can contribute to fat accumulation in the liver.
• Increased Physical Activity: Engaging in regular exercise to burn fat and improve liver function.

This approach can be quite restrictive. It often requires individuals to significantly alter their eating habits, cutting out many foods they enjoy. The strictness of this diet can make it difficult to adhere to over the long term, potentially leading to frustration and relapse. Many people find it hard to keep up long enough to see tangible results.

Alongside Diet: Nutrients the Liver Works With

Several nutrients take part in how the liver handles fat:

• Choline is needed to package fat into VLDL particles and export it from the liver; it contributes to normal lipid metabolism and to the maintenance of normal liver function.
• Inositol is a building block of cell-membrane phospholipids involved in insulin signalling, and it is being studied for insulin sensitivity and liver fat.
• Methionine is an essential amino acid that the liver turns into SAMe, its main methyl donor, which is also used to make phosphatidylcholine, a component of VLDL.
• Taurine is used to conjugate bile acids, which help digest fat, and in laboratory studies it reduces the production of oxidants in mitochondria.
• Zinc is part of the antioxidant enzyme copper-zinc superoxide dismutase and is being studied for its role in the gut barrier.

These nutrients complement the diet and activity changes above; they do not replace them.

If you would like to see how we brought these five nutrients together in one daily drink, with the dose of each, the LiverGuard formula is laid out ingredient by ingredient.

Conclusion

Liver fat, even in small amounts, poses significant health risks. A small rise above the healthy 2-5% can be enough to cross the threshold, and if the disease progresses it can become difficult to reverse and have serious, long-term consequences. Traditional approaches to reducing liver fat often require restrictive diets that can be challenging to maintain. Getting enough of the nutrients the liver works with, above all choline, is a sensible addition to those changes, not a replacement for them. Protecting your liver is critical, and understanding the impact of liver fat is the first step toward better health.

References

1. Farrell, G. C., & Larter, C. Z. (2006). Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis. Hepatology, 43(S1), S99-S112. https://doi.org/10.1002/hep.20973
2. Rinella, M. E. (2015). Nonalcoholic Fatty Liver Disease: A Systematic Review. JAMA, 313(22), 2263-2273. https://doi.org/10.1001/jama.2015.5370
3. Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., … & Sanyal, A. J. (2012). The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Hepatology, 55(6), 2005-2023. https://doi.org/10.1002/hep.25762
4. Zeisel, S. H. (2006). Choline: critical role during fetal development and dietary requirements in adults. Annual Review of Nutrition, 26, 229-250. DOI: 10.1146/annurev.nutr.26.061505.111156
5. Michell, R. H. (2008). Inositol derivatives: Evolution and functions. Nature Reviews Molecular Cell Biology, 9(2), 151-161. https://doi.org/10.1038/nrm2334
6. Brosnan, J. T., & Brosnan, M. E. (2006). The Sulfur-Containing Amino Acids: An Overview. The Journal of Nutrition, 136(6), 1636S-1640S. https://doi.org/10.1093/jn/136.6.1636S
7. Jong, C. J., Azuma, J., & Schaffer, S. (2012). Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids, 42(6), 2223-2232. DOI: 10.1007/s00726-011-0962-7
8. Kleiner, D. E., Brunt, E. M., Van Natta, M., et al. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41(6), 1313-1321. DOI: 10.1002/hep.20701
9. Szczepaniak, L. S., Nurenberg, P., Leonard, D., et al. (2005). Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology – Endocrinology and Metabolism, 288(2), E462-E468. DOI: 10.1152/ajpendo.00064.2004
10. Koutoukidis, D. A., Koshiaris, C., Henry, J. A., et al. (2021). The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism, 115, 154455. DOI: 10.1016/j.metabol.2020.154455
11. Wajchenberg, B. L. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews, 21(6), 697-738. DOI: 10.1210/edrv.21.6.0415
12. Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods (choline: normal lipid metabolism, maintenance of normal liver function, normal homocysteine metabolism). Official Journal of the European Union, L 136, 1-40.

Related reading

• Fatty liver disease (MASLD)
• Insulin resistance and fatty liver
• Beer belly